Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Dual-Task Versus Combined Exercise Training in Older Adults With Type 2 Diabetes

17 settembre 2026 aggiornato da: Gizem Mermerkaya, Bartın Unıversity

L'effetto dell'allenamento dual-task su equilibrio, capacità di esercizio, stato cognitivo e qualità della vita negli individui con diabete mellito di tipo 2

The aim of this randomized controlled study is to investigate the effects of dual-task training on functional mobility, exercise capacity, cognitive function, and quality of life in adults aged 65 years and older with type 2 diabetes mellitus. Changes in serum brain-derived neurotrophic factor (BDNF) levels will also be assessed as a secondary outcome.

The study will compare three groups: dual-task training, combined exercise training, and a control group. Both exercise groups will receive aerobic, resistance, and balance training three times per week for eight weeks. In the dual-task group, participants will perform cognitive tasks targeting memory, verbal fluency, executive function, calculation, and attention concurrently with the physical exercises. The combined exercise group will perform the physical exercises without concurrent cognitive tasks.

The main research question is whether adding simultaneous cognitive tasks to combined exercise training provides additional benefits for functional mobility, assessed using the Timed Up and Go test. The study will also examine effects on exercise capacity, cognitive function, dual-task performance, quality of life, and serum BDNF levels. Outcomes will be compared across the three groups.

Panoramica dello studio

Descrizione dettagliata

Older adults with type 2 diabetes mellitus (T2DM) may experience balance, gait, and cognitive impairments. T2DM is associated with an increased risk of cognitive decline and dementia in older adults. Factors such as insulin resistance, impaired glucose metabolism, advanced glycation end-products, impaired amyloid beta clearance, oxidative stress, and inflammation may contribute to these changes. T2DM has been linked to impairments in episodic memory, verbal fluency, working memory, processing speed, and executive functions. Executive functions are higher-level processes that oversee and regulate other cognitive functions. These capabilities support planning, decision-making, switching between tasks, goal-directed behavior, and coordinating simultaneous activities. Executive function also contributes to the integration of sensory information required for balance and gait. Impairments in these functions may therefore compromise functional mobility and increase fall risk in older adults with T2DM.

Dual-task paradigms are used to examine performance when two tasks are undertaken simultaneously. A primary motor task, such as walking, is combined with a secondary task, and the effects on performance are evaluated. Everyday activities, such as walking while talking, frequently involve these simultaneous demands. When the combined demands of the tasks exceed available attentional resources, performance on one or both tasks may deteriorate. Executive dysfunction may increase this interference. Dual tasks can involve motor-cognitive, cognitive-cognitive, or motor-motor combinations. Previous research has reported adverse effects of dual-task conditions on gait parameters in individuals with T2DM. These findings highlight the importance of considering the interaction between cognitive abilities and motor skills when planning rehabilitation programs.

The effects of dual-task training on balance and cognitive function have been investigated in other populations at increased risk of falls, including stroke survivors, individuals with Parkinson's disease, and older adults with a history of falls. Because cognitive processes contribute to balance and mobility, evaluating physical performance together with cognitive function may provide a more comprehensive understanding of the effects of dual-task training. Previous studies have reported improvements in balance and executive function following dual-task training in older adults. Combined aerobic and resistance exercise has also shown potential benefits for cognition in individuals with T2DM. However, whether adding concurrent cognitive tasks to a combined exercise program provides additional benefits in older adults with T2DM remains unclear.

Brain-derived neurotrophic factor (BDNF) is involved in synaptic plasticity and may provide a biological link between exercise and cognitive function. Nevertheless, reported BDNF responses to exercise in individuals with T2DM have been variable. Assessing serum BDNF alongside functional and cognitive outcomes may help characterize the responses to combined physical and cognitive training, although serum measurements alone cannot establish changes in brain function.

This three-arm randomized controlled study will investigate the effects of dual-task training compared with combined exercise training and a control condition in adults aged 65 years and older with T2DM. Participants will be randomly assigned to the dual-task training group, the combined exercise training group, or the control group. Both exercise groups will undergo aerobic, resistance, and balance training three times per week for eight weeks. The dual-task group will perform the same physical exercise program with concurrent cognitive tasks targeting memory, verbal fluency, executive function, mental arithmetic, and divided attention. The combined exercise group will perform the physical exercises without concurrent cognitive tasks. The control group will receive standardized education on physical activity, glycemic self-monitoring, and reducing sedentary behavior, with weekly telephone contact.

The study will examine whether adding concurrent cognitive tasks to combined exercise training provides additional benefits for functional mobility, assessed using the Timed Up and Go test. Exercise capacity, global cognitive function, executive function, reaction time, dual-task mobility and cost, diabetes-specific quality of life, and serum BDNF levels will also be evaluated before and after the intervention. The study aims to clarify the potential contribution of concurrent cognitive training to rehabilitation in older adults with T2DM.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

45

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Bartın
      • Bartın, Bartın, Turchia (Türkiye), 74000
        • Bartın University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

65 anni e precedenti (Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Being followed up with a diagnosis of Type 2 Diabetes Mellitus for at least 6 months (fasting plasma glucose of 7.0 mmol/L or higher)
  • Not having participated in any structured exercise program for at least 6 months prior.
  • Being willing to volunteer for the study

Exclusion Criteria:

  • Nephropathy
  • Retinopathy
  • Having dementia or Alzheimer's disease
  • Using a walking aid
  • Having ulceration
  • Using balance-curing drugs
  • Surviving myocardial infarction at least 6 months ago
  • Stable or unstable angina pectoris
  • Left ventricular ejection fraction below 40%
  • Peripheral arterial diseases
  • Resting blood pressure above 160/100 mmHg
  • Body mass index above 35 kg/m2
  • Having a history of deep vein thrombosis, pulmonary embolism or stroke in the past

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: dual task exercise group

Patients in the dual-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training. In addition, cognitive exercise training will be incorporated into each session, performed concurrently with the conventional physiotherapy. The cognitive exercises provided in this study are structured to target areas such as memory, verbal fluency, executive functions, calculation, and attention.

Dual task exercise group Patients in the dual-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training. In addition, cognitive exercise training will be incorporated into each session, performed concurrently with the conventional physiotherapy. The cognitive exercises provided in this study are structured to target areas such as memory, verbal fluency, executive functions, calculation, and attentioN Single task exercise group Patients in the single-task training group will undergo 60-minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training.

Comparatore attivo: Combined Exercise Training Group

Patients in the single-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training.

Combined Exercise Training Group Patients in the single-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training.

Nessun intervento: control group

Participants in the control group will be instructed to continue their usual daily activities without participating in a structured exercise training program during the eight-week study period. They will receive standardized education on physical activity, blood glucose self-monitoring, and reducing sedentary behavior, with weekly telephone contact. After the final assessment, participants will be invited to join an exercise training program of their choice.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Time Up and Go Test
Lasso di tempo: Baseline and immediately after the eight-week intervention.

This test is applied to assess the risk of falling and mobility.This test starts with the individual leaving the chair without receiving arm support by giving the go command while sitting in a chair.The distance of 3 meters is asked to return and sit again in the chair.The elapsed time is recorded in seconds.

Baseline and immediately after the eight-week intervention.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Functional exercise capacity Functional Exercise Capacity
Lasso di tempo: Baseline and immediately after the eight-week intervention.

Functional exercise capacity will be assessed using the 6-Minute Walk Test (6MWT). The participants will be instructed to walk at their maximum comfortable pace for 6 minutes along a 30-meter long, flat, and uninterrupted corridor. At the end of the test, the endpoint will be marked, and the total distance walked will be calculated.

Baseline and immediately after the eight-week intervention.
Timed Up and Go Test (Cognitive)
Lasso di tempo: Baseline and immediately after the eight-week intervention.

Participants will be asked to perform both the single-task and cognitive dual-task versions of the Timed Up and Go (TUG) test. In the single-task condition, participants will complete the TUG test without any secondary task. In the cognitive dual-task condition, participants will perform the TUG test while also engaging in a cognitive task, specifically subtracting 3 from 100 repeatedly during the walk.

Baseline and immediately after the eight-week intervention.
Montreal Cognitive Assessment (MoCA)
Lasso di tempo: Baseline and immediately after the eight-week intervention.

Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA). The MoCA is a reliable assessment tool that is particularly effective in testing cognitive levels in individuals with mild cognitive impairment and Alzheimer's disease. It is designed to evaluate various cognitive domains, including attention, memory, language, visuospatial abilities, executive functions, and orientation, providing a comprehensive measure of cognitive health. This tool is widely used in clinical settings for early detection and monitoring of cognitive decline.

Baseline and immediately after the eight-week intervention.
Stroop Test
Lasso di tempo: Baseline and immediately after the eight-week intervention.

The Stroop Test is a widely used psychological test to assess cognitive flexibility, selective attention, and the ability to inhibit cognitive interference. The test is based on the Stroop Effect, which refers to the delay in reaction time when the name of a color is written in a different color ink.

Baseline and immediately after the eight-week intervention.
Diabetes-specific Quality of Life Scale (ADDQoL)
Lasso di tempo: Baseline and immediately after the eight-week intervention.

Diabetes-specific quality of life will be assessed using the Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire. Two global items and the average weighted impact score will be evaluated to assess the perceived impact of diabetes on quality of life.

Baseline and immediately after the eight-week intervention.
Processing Speed
Lasso di tempo: Baseline and immediately after the eight-week intervention.

The processing speed will be evaluated by measuring the reaction time. To measure the reaction time, a FitLight Trainer (Fitlight Sports Corp., Canada) will be used. The FitLight Trainer is primarily used for training purposes and is also suitable for use with older individuals.

Baseline and immediately after the eight-week intervention.
Biochemical Analysis
Lasso di tempo: Baseline and immediately after the eight-week intervention.

Baseline HbA1c levels will be reported to characterize glycemic status. Serum BDNF levels will be assessed before and after the eight-week intervention.

Baseline and immediately after the eight-week intervention.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: gizem mermerkaya, Bartın Unıversity

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

3 dicembre 2024

Completamento primario (Effettivo)

30 novembre 2025

Completamento dello studio (Effettivo)

16 dicembre 2025

Date di iscrizione allo studio

Primo inviato

3 dicembre 2024

Primo inviato che soddisfa i criteri di controllo qualità

5 dicembre 2024

Primo Inserito (Effettivo)

6 dicembre 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

17 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi